Science Explorer Back to mapMap
Discussion
Researcher · Deciphera Pharmaceuticals (United States) · United States

Subha Vogeti

Subha Vogeti publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Cancer-related Molecular Pathways, Cancer Mechanisms and Therapy and Angiogenesis and VEGF in Cancer.

OpenAlex
World rank
#1,617,302
of 7,710,434 ranked researchers
Rank in United States
#502,643
of 1,627,098
Works
27
Citations
936
Citations per work
34.7
h-index
8
i10-index 8Top 87% in Molecular Biology
Subha Vogeti

What does Subha Vogeti research?

Subha Vogeti's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (27%).

Everything else: 10 works · 37.5% of their workHealth Sciences: 10 works · 35.7% of their workMedicine: 10 works · 35.7% of their workPulmonary and Respiratory Medicine: 3 works · 12.5% of their workOncology: 3 works · 10.7% of their workPathology and Forensic Medicine: 2 works · 7.1% of their workRheumatology: 1 works · 5.4% of their workLife Sciences: 7 works · 26.8% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 26.8% of their workMolecular Biology: 6 works · 21.4% of their workCancer Research: 1 works · 5.4% of their workTHEIR WORKSubha Vogeti27works
Life Sciences27%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1037.5%
    1. Medicine1035.7%
    1. Biochemistry, Genetics and Molecular Biology726.8%
  1. 1Molecular Biology21% of their works
  2. 2Pulmonary and Respiratory Medicine12% of their works
  3. 3Oncology11% of their works
  4. 4Pathology and Forensic Medicine7% of their works
  5. 5Rheumatology5% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Subha Vogeti's research?

The keywords of their largest research topics: Cancer Therapy, Prognostic Factors, Cell Cycle, p53, Pim Oncogenes, Tumorigenesis, BRAF gene and endothelial progenitor cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Cancer Therapy72 topics
  2. Prognostic Factors62 topics
  3. Cell Cycle41 topic
  4. Pim Oncogenes41 topic
  5. Tumorigenesis41 topic
  6. p5341 topic
  7. BRAF gene31 topic
  8. Imatinib Mesylate31 topic
  9. MAP Kinase31 topic
  10. Osteosarcoma31 topic
  11. Pigmented Villonodular Synovitis31 topic
  12. Soft Tissue Sarcoma31 topic
  13. Sunitinib31 topic
  14. Synovial Chondromatosis31 topic
  15. VEGF31 topic
  16. endothelial progenitor cells31 topic
  17. HIF-121 topic
  18. Warburg Effect21 topic

Where does Subha Vogeti work?

Subha Vogeti's main affiliation in the publication record is Deciphera Pharmaceuticals (United States), United States.

How many publications and citations does Subha Vogeti have?

OpenAlex counts 27 works and 936 citations for Subha Vogeti, an h-index of 8, ranking #1,617,302 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Subha Vogeti. Posts are plain text and can be reported.